Qualigen Therapeutics(QLGN) - 2025 Q3 - Quarterly Report

Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION | Delaware | 001-37428 | 26-3474527 | | --- | --- | --- | | (State or other jurisdiction | (Commission | (I.R.S. Employer | | of incorporation) | File Number) | Identification No.) | ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 (I.R.S. Employer Identification No.) 5857 Owens Avenue, Suite 300, Carlsbad, California 92008 (Address of p ...